Date published: 2025-12-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr264 Inhibitors

Olr264 inhibitors represent a class of chemical compounds that are specifically designed to modulate the activity of the Olr264 receptor, a member of the olfactory receptor family. These receptors, generally located in the olfactory epithelium, are responsible for detecting and transducing chemical signals into neuronal responses that the brain interprets as smell. The Olr264 receptor, like other olfactory receptors, is a G protein-coupled receptor (GPCR), a class of proteins that play a pivotal role in cellular signaling by activating intracellular pathways in response to the binding of specific ligands. Inhibitors of the Olr264 receptor function by blocking or reducing its ability to interact with its natural ligands, thereby modulating the signal transduction pathways associated with this receptor.

Structurally, Olr264 inhibitors are diverse, reflecting the complex nature of their target receptor. These compounds typically possess molecular frameworks that allow for high affinity and selectivity towards the Olr264 receptor, often incorporating heterocyclic rings, aromatic systems, and various functional groups that can form specific interactions with the receptor's binding site. The design and synthesis of these inhibitors involve careful consideration of the receptor's three-dimensional structure, including its active site geometry and the physicochemical properties of the binding pocket. Through techniques such as structure-activity relationship (SAR) studies and computational modeling, researchers are able to optimize these inhibitors to achieve maximum potency and selectivity. Moreover, the investigation of Olr264 inhibitors provides valuable insights into the broader field of olfactory receptor biology and the fundamental mechanisms underlying chemosensory perception.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Metformin

657-24-9sc-507370
10 mg
$77.00
2
(0)

Activates AMPK, potentially modulating pathways that Olr264 might be involved in, thereby affecting its activity.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

Inhibits the SERCA pump, affecting calcium homeostasis, which could influence Olr264 activity.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$226.00
$846.00
1
(0)

Bromodomain inhibitor, affects transcription regulation and could alter Olr264 expression.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$96.00
$250.00
$750.00
$1428.00
280
(6)

V-ATPase inhibitor, affects lysosomal acidification, potentially impacting Olr264's function or degradation.

Torin 1

1222998-36-8sc-396760
10 mg
$240.00
7
(1)

mTOR inhibitor, can modulate mTOR signaling pathways, potentially influencing Olr264's activity.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$150.00
$349.00
15
(1)

Aurora kinase inhibitor, affects cell cycle regulation, potentially impacting Olr264 activity.

LY3214996

1951483-29-6sc-507299
5 mg
$260.00
(0)

ERK1/2 inhibitor, potentially affecting MAPK signaling pathways and Olr264's role in them.

SB-216763

280744-09-4sc-200646
sc-200646A
1 mg
5 mg
$70.00
$198.00
18
(1)

GSK-3 inhibitor, could modulate Wnt signaling, potentially affecting Olr264's activity.

Palbociclib

571190-30-2sc-507366
50 mg
$315.00
(0)

CDK4/6 inhibitor, affects cell cycle progression, potentially influencing Olr264 function.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

MEK inhibitor, affects MAPK/ERK pathway, potentially influencing Olr264's signaling cascade.